The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

MeiraGTx is advancing its investigational gene therapy toward expedited approval in the UK after 11 children who were born ...

The study introduces a Conditional Generative AI Model designed to create synthetic full-body CT scans based on patient ...

A total of 100 primary prevention children were included (7.1±5.6 years ... for PRIMaCY (>8.3%), with 1 patient potentially treated by ICD for every 25 ICDs implanted for HCM Risk-Kids and 1 for every ...

Undiagnosed mental health sufferers hurt their loved ones along with others by lacking proper treatment particularly when ...

NexoBrid ® is a topically administered biological orphan drug that enzymatically removes eschar while preserving viable ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

Scleral lenses demonstrated safety and efficacy for treating ocular surface disease and irregular cornea/refractive ...

The EarliPoint evaluation tool tracks eye movement in children to screen for autism. A new diagnostic tool is allowing ...